Huma Therapeutics. has filed a patent for a device predicting heart rate variability parameters for users. The device processes heart rate measurements over time, estimates data sufficiency, and outputs valid parameters with an uncertainty score. This innovation aims to enhance heart health monitoring. GlobalData’s report on Huma Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Huma Therapeutics, Medical event scoring was a key innovation area identified from patents. Huma Therapeutics's grant share as of January 2024 was 43%. Grant share is based on the ratio of number of grants to total number of patents.
Device for predicting heart rate variability parameter for user
See Also:
A newly filed patent (Publication Number: US20240000327A1) describes a device designed to predict a heart rate variability parameter for a user. The device includes processing modules that receive a set of heart rate measurements over a period of time, calculate the heart rate variability parameter, estimate the sufficiency of the data set, and determine the validity of the parameter based on an uncertainty score. If the parameter is valid, the device outputs the heart rate variability parameter and the uncertainty score. The set of heart rate measurements can be obtained from an external device like a wrist-worn fitness tracker, either directly or via a network storing the data. The device aims to determine if the heart rate variability parameter is indicative of cardiovascular disease.
Furthermore, the patent also includes a method for predicting a heart rate variability parameter using the described device. The method involves receiving heart rate measurements, processing them to calculate the parameter, estimating the sufficiency of the data set, determining the validity of the parameter based on the uncertainty score, and outputting the parameter and uncertainty score if valid. The device can output the results on its display for user reference. The heart rate variability parameter is calculated based on the standard deviation of the inter-beat interval of sinus beats over a 24-hour period, specifically focusing on ultra-low frequency spectrum heart rate measurements. The method aims to provide a reliable prediction of the heart rate variability parameter for users, potentially aiding in the early detection of cardiovascular issues.
To know more about GlobalData’s detailed insights on Huma Therapeutics, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
